• Midbrain organoids closely resemble the human midbrain in structure and cell types.
▶ Resemble human midbrain in structure, cell types for accurate studies.
• Midbrain organoids provide reliable data for testing the efficacy and toxicity of new drugs.
▶ Provide reliable data for testing drug efficacy, toxicity effectively.
• Midbrain organoids enable the study of early human brain development processes.
▶ Study early human brain development processes facilitated by midbrain organoids.

• Cerebral organoids enable research on tissues and cells that are difficult to obtain from humans.
▶ Research on inaccessible human brain tissues and cells enabled.
• Cerebral organoids provide a human-like environment to test the efficacy and toxicity of various neurological drugs.
▶ Human-like environment for testing neurological drug efficacy, toxicity.
• Cerebral organoids can be genetically modified to study the pathological mechanisms of brain diseases like Alzheimer's, epilepsy, and other neurodevelopmental disorders.
▶ Genetically modified to study Alzheimer's, epilepsy, brain diseases' mechanisms.

• Lung alveolar organoids mimic the complex structure of alveoli, providing a realistic model for studying respiratory physiology and diseases.
▶ Mimic alveolar structure, study respiratory diseases in lab setting.
• They allow for the study of lung diseases such as pulmonary fibrosis and respiratory infections in a controlled laboratory setting.
▶ Study pulmonary fibrosis, infections in controlled lab settings.
• Lung alveolar organoids are used to test the efficacy and toxicity of drugs targeting respiratory conditions, offering insights into potential treatments and therapies.
▶ Test drugs for respiratory conditions' efficacy, toxicity, inform therapies.

• Retinal organoids replicate the diverse cell types found in the human retina, allowing for detailed studies of retinal development and function.
▶ Retinal organoids replicate human retina for detailed developmental studies.
• They serve as models for studying retinal diseases like retinitis pigmentosa and age-related macular degeneration, aiding in disease understanding and therapeutic development.
▶ Models for retinal diseases aid understanding and therapy development.
• Retinal organoids are used to screen potential drugs for retinal disorders, providing a platform to assess drug efficacy and safety in a controlled experimental environment.
▶ Screen drugs for retinal disorders' efficacy and safety accurately.

• Possess characteristics of adenoid epithelial cells.
• High generation and growth rates from adenoid tissue.
• Capable of being infected by viruses (e.g., adenovirus).

• Possess characteristics of tonsil epithelial cells.
• Exhibit a consistent organoid morphology with minimal variation across different tissues.
• Capable of being infected by viruses (e.g., SARS-CoV-2, HPV).

• Histologically similar to lacrimal gland tissue
• Expression of lacrimal gland-specific markers is similar to that in normal lacrimal gland tissue.
• Functional response to pilocarpine with increased internal Ca2+ and β-hexosaminidase levels.

• Histologically similar to salivary gland tissue
• Mimics the functional characteristics of salivary gland tissue.
• Composed of various cell types, including acinar and ductal cells.

• Cardiac Organoids: Lifelike Functionality
▶ Experience the rhythmic pulseof our cardiac organoids, mimicking real human heart functionality for groundbreaking research.
• Simplified Cultivation: Enhanced Efficiency
▶ Our cultivation process eliminates extracellular matrices, reducing variabilityand maximizing the efficiencyof functional cardiac organoid production.
• Advanced Differentiation: Superior Maturation
▶ We've refined our differentiation methods to better replicate the human heart, achieving a precise balanceof myocardialand non-myocardial cells for more mature organoid functions.

• Highly Predictive Models

▶ Utilize our kidney organoids for precise toxicity assessments and efficacy evaluations, offering models that closely mimic human kidney responses.

• Accelerated Testing Capabilities

▶ Speed up your drug development process with our organoids that allow for rapid and accurate testing of renal toxicity and therapeutic effectiveness.

• Cost-Effective Research Tool

▶ Reduce research costs with our kidney organoids, which require fewer resources than traditional animal models while providing detailed insights into nephrotoxic effects and drug interactions.